EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Osimertinib’s Proton-Catalyzed, Pseudoconcerted EGFR Inhibition Guides Next-Generation Inhibitor Design

Akihiro Kondo, Kazuhiro J Fujimoto iD, Shin-Ichi Koda iD, Shinji Saito iD, Takeshi Yanai iD

Journal of Chemical Information and Modeling · 2026

DOI: 10.1021/acs.jcim.5c02787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2026. Verfasst von Akihiro Kondo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Graduate School of Science, Nagoya University, Furocho, Chikusa, Nagoya 464-8601, Japan. Hauptthemen laut MEDLINE: Acrylamides, ErbB Receptors, Aniline Compounds, Protein Kinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Core Research for Evolutional Science and Technology, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcrylamidesErbB ReceptorsAniline CompoundsProtein Kinase InhibitorsProtonsDrug DesignCatalysisThermodynamicsHumansMolecular Dynamics SimulationIndolesPyrimidines

Substanzen

osimertinibAcrylamidesErbB ReceptorsAniline CompoundsProtein Kinase InhibitorsProtonsEGFR protein, humanIndolesPyrimidines

Autor:innen und Institutionen

  • Department of Chemistry, Graduate School of Science, Nagoya University, Furocho, Chikusa, Nagoya 464-8601, Japan.
  • Institute of Transformative Bio-Molecules (WPI-ITbM), Nagoya University, Furocho, Chikusa, Nagoya 464-8601, Japan.
  • Department of Theoretical and Computational Molecular Science, Institute for Molecular Science, Myodaiji, Okazaki, Aichi 444-8585, Japan.
  • School of Physical Sciences, The Graduate University for Advanced Studies, Myodaiji, Okazaki, Aichi 444-8585, Japan.

ORCID-Profile: Kazuhiro J Fujimoto, Shin-Ichi Koda, Shinji Saito, Takeshi Yanai

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • Core Research for Evolutional Science and Technology
  • Japan Society for the Promotion of Science

Zitieren

APA

Kondo, A., Fujimoto, K. J., Koda, S. I., Saito, S., & Yanai, T. (2026). Osimertinib’s Proton-Catalyzed, Pseudoconcerted EGFR Inhibition Guides Next-Generation Inhibitor Design. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.5c02787

Vancouver

Kondo A, Fujimoto KJ, Koda SI, Saito S, Yanai T. Osimertinib’s Proton-Catalyzed, Pseudoconcerted EGFR Inhibition Guides Next-Generation Inhibitor Design. Journal of Chemical Information and Modeling. 2026. doi:10.1021/acs.jcim.5c02787

BibTeX
@article{Kondo2026,
  author = {Kondo, Akihiro and Fujimoto, Kazuhiro J and Koda, Shin-Ichi and Saito, Shinji and Yanai, Takeshi},
  title = {Osimertinib’s Proton-Catalyzed, Pseudoconcerted EGFR Inhibition Guides Next-Generation Inhibitor Design},
  journal = {Journal of Chemical Information and Modeling},
  year = {2026},
  doi = {10.1021/acs.jcim.5c02787}
}
Kostenlos starten →